Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Randox’s Cytokine Array utilised in diagnostic assessment of stress

Randox’s Cytokine Array utilised in diagnostic assessment of stress

10th March 2008

Randox has developed a biochip which is able to assess stress levels.

The Cytokine Array biochip has been utilised in Goteberg University and the Nobel Prize-awarding Karolinska Institute in Sweden’s screening and diagnostic assessment of stress.

During the study, 270 patients on long-term sick-leave for stress-induced affective disorder were compared with healthy individuals.

Their blood samples were analysed for cytokines, hormones, growth factors and other biochemical parameters.

It was found that 82 per cent of the stressed participants fulfilled DSM-IV criteria for Major Depressive Disorder – making the results clinically significant.

Levels of the markers MCP-1, VEGF and EGF were all found to be directly related to stress levels.

Biochip array technology enables the simultaneous assessment of up to 12 cytokines from one patient sample using a single biochip. Four Cytokine Arrays are currently available from Randox for the assessment of stress and other conditions.

This follows news that a biochip screening test from Randox is able to test for a number of growth promoter drug residues.
ADNFCR-1050-ID-18501387-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.